Matthew R. Lammi
Louisiana State University(US)Johns Hopkins University(US)Johns Hopkins Medicine(US)University Medical Center New Orleans(US)Library Network(US)Johns Hopkins Hospital(US)Louisiana State University Health Sciences Center New Orleans(US)
Publications by Year
Research Areas
Pulmonary Hypertension Research and Treatments, Systemic Sclerosis and Related Diseases, Chronic Obstructive Pulmonary Disease (COPD) Research, Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis, Respiratory Support and Mechanisms
Most-Cited Works
- → Metoprolol for the Prevention of Acute Exacerbations of COPD(2019)172 cited
- → Health-Related Quality of Life (HRQoL) in Sarcoidosis: Diagnosis, Management, and Health Outcomes(2021)71 cited
- → Clinical Differences and Outcomes between Methamphetamine-associated and Idiopathic Pulmonary Arterial Hypertension in the Pulmonary Hypertension Association Registry(2020)58 cited
- → Response to Fluid Boluses in the Fluid and Catheter Treatment Trial(2015)52 cited
- → PARP inhibition by olaparib or gene knockout blocks asthma-like manifestation in mice by modulating CD4+ T cell function(2015)48 cited
- → DNA-dependent protein kinase inhibition blocks asthma in mice and modulates human endothelial and CD4+ T-cell function without causing severe combined immunodeficiency(2014)44 cited